HIMS Stock Craters - Is It a Buying Opportunity?Hims & Hers Health faces challenges after the FDA resolved the semaglutide shortage, impacting their growth from compounding drug sales.
Markets Today: Dow Down, HD Rises, HIMS SinksWeaker consumer confidence has undermined market gains, despite some strong earnings from Home Depot.
HIMS Stock Craters - Is It a Buying Opportunity?Hims & Hers Health faces challenges after the FDA resolved the semaglutide shortage, impacting their growth from compounding drug sales.
Markets Today: Dow Down, HD Rises, HIMS SinksWeaker consumer confidence has undermined market gains, despite some strong earnings from Home Depot.
Hims & Hers stock surges 23%: Telehealth company announces expansion into blood testing weeks after Super Bowl buzzHims & Hers is expanding into at-home blood testing to enhance personal healthcare through technology.
Hims & Hers markets itself in a very 2025 way: by picking a fightHims & Hers targets Big Pharma with a Super Bowl ad promoting a cheaper weight-loss drug, reflecting anti-establishment sentiments.
Hims & Hers stock surges 23%: Telehealth company announces expansion into blood testing weeks after Super Bowl buzzHims & Hers is expanding into at-home blood testing to enhance personal healthcare through technology.
Hims & Hers markets itself in a very 2025 way: by picking a fightHims & Hers targets Big Pharma with a Super Bowl ad promoting a cheaper weight-loss drug, reflecting anti-establishment sentiments.
Owner of Hims & Hers Healthcare Company, and New West Portal Doughnut Shop, Donates to Trump InaugurationHims & Hers CEO Andrew Dudum donated $1 million to Trump's inauguration fund to align with potential favorable healthcare policies for his business.
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is overHims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.